Status
N/A
financed
Share
Funding data
Raised
USD
19,678,189.03
Details
Country
Canada
Sector
HealthcareHealthcare
Description
“SaNOtize is conducting Phase II clinical trials in Canada and the UK of a nasal spray based on nitric oxide as a prevention and early treatment against COVID-19.”